Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Smith & Nephew Snats ADR (SNN)

Smith & Nephew Snats ADR (SNN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Smith & Nephew Snats ADR BUILDING 5 CROXLEY PARK HATTERS LANE WATFORD X0 WD18 8YE GBR

www.smith-nephew.com Employees: 18,452 P: 44-19-2347-7100

Description:

Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world

Key Statistics

Overview:

Market Capitalization, $K 10,772,288
Enterprise Value, $K 12,789,288
Shares Outstanding, K 437,187
Annual Sales, $ 5,549 M
Annual Net Income, $ 263,000 K
Last Quarter Sales, $ 1,249 M
Last Quarter Net Income, $ 160,000 K
EBIT, $ 0 K
EBITDA, $ 1,108 M
60-Month Beta 0.85
% of Insider Shareholders 1.00%
% of Institutional Shareholders 25.64%
Float, K 432,815
% Float 99.00%
Short Volume Ratio 0.56

Growth:

1-Year Return -3.11%
3-Year Return -28.13%
5-Year Return -43.52%
5-Year Revenue Growth 13.15%
5-Year Earnings Growth -17.82%
5-Year Dividend Growth 2.82%

Per-Share Information:

Next Earnings Date 02/27/24
Earnings Per Share ttm 0.00
EPS Growth vs. Prev Qtr 57.52%
EPS Growth vs. Prev Year 0.18%
Annual Dividend Rate, $ 0.73
Annual Dividend Yield 2.94%
Most Recent Dividend 0.273 on 10/04/24
Next Ex-Dividends Date 10/04/24
Dividend Payable Date 11/08/24
Dividend Payout Ratio 0.00%
Most Recent Split 5-2 on 10/15/14

SNN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 14.57
Price/Earnings to Growth 1.28
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % 4.74%
Debt/Equity 0.63
Price/Sales 1.94
Price/Cash Flow 7.66
Price/Book 2.07
Book Value/Share 11.91
Interest Coverage 3.20

SNN Dividends

Date Value
10/04/24 $0.2730
04/01/24 $0.4520
10/05/23 $0.2780
03/30/23 $0.4520
09/29/22 $0.2780
03/31/22 $0.4520
09/30/21 $0.2780
04/05/21 $0.4520
10/01/20 $0.2780
04/02/20 $0.4520
10/03/19 $0.2780
04/04/19 $0.4300
10/04/18 $0.2700
04/05/18 $0.4440
10/05/17 $0.2360
03/29/17 $0.3700
10/05/16 $0.2360
04/20/16 $0.3700
10/07/15 $0.2260
04/15/15 $0.3720
10/22/14 $0.2200
04/17/14 $0.8500
10/09/13 $0.5200
04/17/13 $0.8100
10/10/12 $0.4950
04/18/12 $0.5400
10/12/11 $0.3300
04/29/11 $0.4910
10/13/10 $0.3000
04/21/10 $0.4465
10/14/09 $0.2730
04/15/09 $0.4060
10/15/08 $0.2480
04/16/08 $0.3690
10/17/07 $0.2255
04/18/07 $0.3317
10/18/06 $0.2050
04/19/06 $0.3050
10/19/05 $0.1884
04/20/05 $0.2969
10/20/04 $0.1710
04/21/04 $0.2714
08/13/03 $0.2979
04/17/03 $0.5428
10/16/02 $0.3135
04/17/02 $0.4566
11/07/01 $0.2782
04/18/01 $0.4511
11/08/00 $0.2470
05/04/00 $0.6950
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar